The Global Albinism Drug Market is projected to reach USD 320.78 million by 2032, expanding at a CAGR of 7.45% during 2025–2032. This report analyzes market dynamics, segmentation, drivers, restraints, opportunities, and competitive landscape, based exclusively on Data Bridge Market Research insights. Understanding Albinism Therapeutics Albinism therapeutics aim...